Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Carolina Ortiz-Lopez

Concepts (97)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Contrast Media
4
2016
493
0.840
Why?
Fatty Liver
5
2014
252
0.600
Why?
Lower Extremity
3
2016
453
0.480
Why?
Radiography, Interventional
2
2016
128
0.480
Why?
Triiodobenzoic Acids
1
2014
6
0.430
Why?
Non-alcoholic Fatty Liver Disease
8
2016
265
0.420
Why?
Peripheral Arterial Disease
3
2016
507
0.400
Why?
Prediabetic State
2
2016
250
0.370
Why?
Diabetic Angiopathies
1
2014
265
0.370
Why?
Coronary Angiography
1
2014
325
0.350
Why?
Ischemia
1
2014
421
0.330
Why?
Pain
1
2014
790
0.290
Why?
Vascular Access Devices
2
2015
30
0.220
Why?
Overweight
3
2015
614
0.200
Why?
Catheterization, Peripheral
2
2015
116
0.200
Why?
Point-of-Care Systems
1
2025
185
0.190
Why?
Diabetes Mellitus
1
2012
1101
0.190
Why?
Obesity
5
2016
3131
0.190
Why?
Internal Medicine
1
2025
280
0.180
Why?
Endovascular Procedures
2
2016
390
0.160
Why?
Curriculum
1
2025
1079
0.140
Why?
Diabetes Mellitus, Type 2
4
2016
2623
0.130
Why?
Hyperinsulinism
2
2016
115
0.120
Why?
Insulin Resistance
6
2016
1247
0.120
Why?
Angiography, Digital Subtraction
1
2015
51
0.110
Why?
Thiazolidinediones
1
2016
142
0.110
Why?
Angiography
1
2016
206
0.110
Why?
Internship and Residency
1
2025
1281
0.110
Why?
Popliteal Artery
1
2015
60
0.110
Why?
Arterial Occlusive Diseases
1
2015
88
0.100
Why?
Severity of Illness Index
4
2015
2921
0.100
Why?
Liver
4
2016
1864
0.100
Why?
Keratin-18
1
2013
12
0.100
Why?
Radiography
1
2014
861
0.090
Why?
Liver Cirrhosis
1
2013
278
0.080
Why?
Hyperglycemia
2
2012
384
0.080
Why?
Case-Control Studies
3
2014
3647
0.080
Why?
Diabetes Complications
1
2012
219
0.080
Why?
Metabolome
1
2012
390
0.070
Why?
Middle Aged
10
2016
36619
0.070
Why?
Acute Kidney Injury
1
2016
866
0.070
Why?
Adipose Tissue
1
2012
642
0.060
Why?
Ultrasonography
2
2025
788
0.060
Why?
Male
11
2016
73396
0.060
Why?
Humans
14
2025
146342
0.060
Why?
Hypoglycemic Agents
1
2016
1412
0.060
Why?
Female
11
2016
79499
0.060
Why?
Prevalence
1
2012
2861
0.050
Why?
Triglycerides
2
2016
527
0.050
Why?
Delphi Technique
1
2025
350
0.050
Why?
Glucose Clamp Technique
2
2016
199
0.050
Why?
Predictive Value of Tests
2
2015
2113
0.040
Why?
Incidence
2
2016
2936
0.030
Why?
Clinical Competence
1
2025
1272
0.030
Why?
Transaminases
1
2016
22
0.030
Why?
Diet, Reducing
1
2016
90
0.030
Why?
Punctures
1
2015
40
0.030
Why?
Body Mass Index
2
2016
2458
0.030
Why?
Cholesterol, HDL
1
2016
201
0.030
Why?
Models, Anatomic
1
2015
87
0.030
Why?
Adult
3
2016
41087
0.030
Why?
Glucose Tolerance Test
1
2016
360
0.030
Why?
Vascular Patency
1
2015
115
0.030
Why?
Models, Cardiovascular
1
2015
194
0.030
Why?
Femoral Artery
1
2015
183
0.030
Why?
Drug Administration Schedule
1
2016
790
0.030
Why?
Dyslipidemias
1
2016
184
0.030
Why?
Cholesterol, LDL
1
2016
363
0.030
Why?
Texas
1
2015
280
0.030
Why?
Insulin
2
2016
2525
0.030
Why?
Equipment Design
1
2015
520
0.020
Why?
Comparative Effectiveness Research
1
2015
171
0.020
Why?
Biomarkers
2
2016
4340
0.020
Why?
ROC Curve
1
2015
617
0.020
Why?
Magnetic Resonance Spectroscopy
1
2015
627
0.020
Why?
Weight Gain
1
2016
562
0.020
Why?
Radioimmunoassay
1
2012
162
0.020
Why?
Biopsy
1
2015
1075
0.020
Why?
Biopsy, Needle
1
2012
183
0.020
Why?
Animals
1
2014
38107
0.020
Why?
Double-Blind Method
1
2016
2070
0.020
Why?
Risk Factors
2
2016
10921
0.020
Why?
Age Distribution
1
2012
399
0.020
Why?
Adiposity
1
2016
533
0.020
Why?
Sex Distribution
1
2012
382
0.020
Why?
Reference Values
1
2012
796
0.020
Why?
Treatment Outcome
2
2016
11821
0.020
Why?
Diagnosis, Differential
1
2014
1503
0.020
Why?
Analysis of Variance
1
2012
1298
0.020
Why?
Renal Insufficiency, Chronic
1
2015
640
0.020
Why?
Immunohistochemistry
1
2012
1712
0.020
Why?
United States
1
2025
16136
0.020
Why?
Risk Assessment
1
2016
3712
0.010
Why?
Registries
1
2015
2400
0.010
Why?
Cohort Studies
1
2016
6077
0.010
Why?
Aged
2
2015
26432
0.010
Why?
Prognosis
1
2012
4351
0.010
Why?
Ortiz-Lopez's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)